|
TESK2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.57747999999236E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.635000E-03 |
| Normal-vs-Stage2 |
1.502240E-03 |
| Normal-vs-Stage3 |
1.438340E-04 |
| Normal-vs-Stage4 |
6.91460000368238E-10 |
| Stage1-vs-Stage2 |
1.329620E-01 |
| Stage1-vs-Stage3 |
4.923700E-02 |
| Stage1-vs-Stage4 |
2.4934000000254E-06 |
| Stage2-vs-Stage3 |
8.986600E-01 |
| Stage2-vs-Stage4 |
8.534000E-02 |
| Stage3-vs-Stage4 |
7.219700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.19539999999352E-05 |
| Normal-vs-AfricanAmerican |
4.152100E-04 |
| Normal-vs-Asian |
9.141600E-01 |
| Caucasian-vs-AfricanAmerican |
2.055800E-01 |
| Caucasian-vs-Asian |
2.750600E-01 |
| AfricanAmerican-vs-Asian |
1.573230E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.19969999999403E-05 |
| Normal-vs-Female |
1.566980E-04 |
| Male-vs-Female |
8.566800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.113820E-02 |
| Normal-vs-Age(41-60Yrs) |
1.318440E-03 |
| Normal-vs-Age(61-80Yrs) |
2.90169999994649E-06 |
| Normal-vs-Age(81-100Yrs) |
2.404000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.647800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.079600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.653400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.158600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.664200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.844800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.042200E-01 |
| Normal-vs-Grade 2 |
3.707700E-02 |
| Normal-vs-Grade 3 |
1.12730000001449E-06 |
| Normal-vs-Grade 4 |
4.75874895045081E-12 |
| Grade 1-vs-Grade 2 |
6.987900E-02 |
| Grade 1-vs-Grade 3 |
4.504700E-03 |
| Grade 1-vs-Grade 4 |
2.42080000045775E-07 |
| Grade 2-vs-Grade 3 |
1.276650E-03 |
| Grade 2-vs-Grade 4 |
1.8146000257957E-09 |
| Grade 3-vs-Grade 4 |
2.679000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.430840E-01 |
| Normal-vs-ccB subtype |
4.73890000018962E-07 |
| ccA subtype-vs-ccB subtype |
2.08029999999582E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.363500E-04 |
| Normal-vs-N1 |
4.32850000000595E-05 |
| N0-vs-N1 |
1.144440E-01 |
|
|
